New medications and treatments for ovarian cancer are constantly being developed. These must be shown to be safe and effective before doctors can prescribe them to patients. Through clinical trials, researchers test the effects of new drugs on a group of volunteers with ovarian cancer. Following a strict protocol and using carefully controlled conditions, researchers evaluate the investigational drugs under development and measure the ability of the new drug to treat ovarian cancer, its safety, and any possible side effects.
Some patients with ovarian cancer are reluctant to take part in clinical trials for fear of getting no treatment at all. Patients who participate in clinical trials may receive the most effective therapy available for their condition -- or they may receive treatments that are being evaluated for future use. The drugs being tested may be even more effective than the current ovarian cancer treatment. The specifics about a particular clinical trial should be discussed with your doctor.
Depending on your stage of life and risk for ovarian cancer, you should discuss with your doctor the pros and cons of using birth control pills. Low-dose birth control pills are considered protective. Some studies suggest that women who take hormone replacement therapy after menopause may have an increased risk of ovarian cancer.
If you are at high risk for ovarian cancer, ask your doctor about available tests for ovarian cancer screening, including blood work, transvaginal ultrasound, and recto-vaginal...
This web site, developed by the nonprofit Coalition of Cancer Cooperative Groups, is an unbiased cancer clinical trial matching and navigation service enabling patients to search for cancer trials based on disease and location.